Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2024) 99 P221 | DOI: 10.1530/endoabs.99.P221

1Cochin Institute, Paris, France; 2Hospices civils de Lyon, Endocrinology, Brons, France; 3Lille University Hospital, Endocrinology, Diabetology, Metabolism and Nutrition, Lille, France; 4Cochin Hospital, Endocrinology, Paris, France; 5Cochin Hospital, Department of Tumors and Cancers Molecular Medicine, Paris, France; 6Nice University Hospital, Department of Endocrinology, Diabetology and Reproductive medicine, Nice, France; 7Necker University Hospital, APHP, Department of Pediatric Endocrinology, Gynecology and Diabetology, Paris


Objective: We have described constitutional duplications of the PRKACA gene locus (encoding the catalytic subunit of the Protein Kinase A) in rare cases of bilateral nodular adrenocortical cause of Cushing’s (Beuschlein et al, NEJM 2014). Its frequency in macronodular and micronodular adrenal diseases and the occurrence of others manifestation of Carney complex are not clearly established. This study performs its systematic screening in a large cohort of adrenocortical nodular disease patients and describes its phenotype.

Methods: Between 2020 and 2023, 487 consecutive index cases with bilateral macronodular adrenal hyperplasia (n=442) or Primary Pigmented Nodular Adrenocortical Disease (PPNAD)/Carney Complex (CNC) (n=45) were genotyped with a targeted NGS panel including the exonic and intronic flanking regions of the ARMC5, MEN1, PRKAR1A (CNC) and PRKACA genes. Familial screening was then offered to relatives. Whole genome sequencing was performed when accepted in index cases with PRKACA duplications.

Results: Constitutional duplications of PRKACA were identified in 5 index cases (representing 11% of patients with PPNAD or CNC) and 7 of the 11 screened relatives, supporting the involvement of the PRKACA oncogene through a constitutional copy gain mechanism. Sex ratio was 1 male/2 female. The whole genome sequencing performed for 4 index cases did not find any other gene involved in human disease in the duplicated region, nor any other alteration in genes implicated in adrenal tumors. All index cases had PPNAD responsible for Cushing’s syndrome and ACTH-independent hypercortisolism, diagnosed at a median of 20 years (range: 9–32). The adrenals were described as normal on conventional imaging in 3/5 cases, but iodocholesterol scintigraphy showed diffuse bilateral uptake. They presented with high 24 h Urinary Free Cortisol (UFC) (range: 2.3 - 9.8 × upper limit of normal) and no response to Dexamethasone suppression test. A paradoxical rise in 24 h UFC after Dexamethasone (Liddle’s test) was observed in 3 patients (1 index and 2 relatives). All patients with Cushing syndrome were treated by bilateral adrenalectomy. Almost no significant manifestations of CNC were observed apart from PPNAD (median follow-up of 10 years [5–16]): mainly lentigines and testicular calcifications in one male patient.

Conclusion: Constitutional duplication of PRKACA is a rare cause of PPNAD. It does not appear to be involved in other forms of adrenocortical nodular disease, nor is it frequently associated with other manifestations of CNC. Constitutional duplication of PRKACA should be searched in the absence of a pathogenic PRKAR1A variant in patients with PPNAD.

Volume 99

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.